 | VUC | Name: | (2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid | Formula: | C13 H18 Cl2 N2 O2 | SMILES: | N[CH](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O | InChi: | InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1 | Synonyms: | melphalan | Definition date: | 2023-08-18 | Last modified: | 2025-02-07 | Release date: | 2025-02-12 | Identifier: | (2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid |
|
 | A1LXR | Name: | Cer(d18:0/20:0) | Formula: | C38 H77 N O3 | SMILES: | CCCCCCCCCCCCCCCCCCCC(=O)N[CH](CO)[CH](O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C38H77NO3/c1-3-5-7-9-11-13-15-17-18-19-20-22-24-26-28-30-32-34-38(42)39-36(35-40)37(41)33-31-29-27-25-23-21-16-14-12-10-8-6-4-2/h36-37,40-41H,3-35H2,1-2H3,(H,39,42)/t36-,37+/m0/s1 | Synonyms: | N-(eicosanoyl)-dihydroceramide | Definition date: | 2024-02-05 | Last modified: | 2025-02-06 | Release date: | 2025-02-05 | Identifier: | ~{N}-[(2~{S},3~{R})-1,3-bis(oxidanyl)octadecan-2-yl]icosanamide |
|
 | MCO | Name: | 1-(3-MERCAPTO-2-METHYL-PROPIONYL)-PYRROLIDINE-2-CARBOXYLIC ACID | Formula: | C9 H15 N O3 S | SMILES: | OC(=O)C1CCCN1C(=O)C(C)CS | InChi: | InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7-/m1/s1 | Definition date: | 2001-08-28 | Last modified: | 2025-02-06 | Identifier: | 1-[(2S)-2-methyl-3-sulfanylpropanoyl]-D-proline |
|
 | PSE | Name: | O-PHOSPHOETHANOLAMINE | Formula: | C3 H10 N O5 P | SMILES: | O=P(O)(O)OCC(N)CO | InChi: | InChI=1S/C3H10NO5P/c4-3(1-5)2-9-10(6,7)8/h3,5H,1-2,4H2,(H2,6,7,8)/t3-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2025-02-05 | Identifier: | (2R)-2-amino-3-hydroxypropyl dihydrogen phosphate |
|
 | 9Y6 | Name: | (2E)-3-phenylprop-2-enal | Formula: | C9 H8 O | SMILES: | c1cccc(c1)C=[C@H]C=O | InChi: | InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+ | Synonyms: | Trans-Cinnamaldehyde | Definition date: | 2018-08-29 | Last modified: | 2025-02-03 | Release date: | 2019-08-14 | Identifier: | (2E)-3-phenylprop-2-enal |
|
 | ZSI | Name: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2R,3S,4S)-2,3,4-trihydroxy-5-[(1R,3S,3aS,13R)-1-hydroxy-10,11-dimethyl-3-[3-(methylcarbamoyl)phenyl]-4,6-dioxo-2,3,5,6-tetrahydro-1H-benzo[g]pyrrolo[2,1-e]pteridin-8(4H)-yl]pentyl dihydrogen diphosphate (non-preferred name) | Formula: | C38 H46 N10 O17 P2 | SMILES: | CNC(=O)c1cccc(c1)C1CC(O)N2c3cc(C)c(C)cc3N(CC(O)C(O)C(O)COP(=O)(O)OP(=O)(O)OCC3OC(n4cnc5c(N)ncnc54)C(O)C3O)C3=NC(=O)NC(=O)C123 | InChi: | InChI=1S/C38H46N10O17P2/c1-16-7-21-22(8-17(16)2)48-26(51)10-20(18-5-4-6-19(9-18)33(55)40-3)38(48)35(44-37(57)45-36(38)56)46(21)11-23(49)28(52)24(50)12-62-66(58,59)65-67(60,61)63-13-25-29(53)30(54)34(64-25)47-15-43-27-31(39)41-14-42-32(27)47/h4-9,14-15,20,23-26,28-30,34,49-54H,10-13H2,1-3H3,(H,40,55)(H,58,59)(H,60,61)(H2,39,41,42)(H,45,56,57)/t20-,23-,24+,25+,26+,28-,29+,30+,34+,38-/m0/s1 | Definition date: | 2023-03-29 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (2R,3S,4S)-2,3,4-trihydroxy-5-[(1R,3S,3aS,13R)-1-hydroxy-10,11-dimethyl-3-[3-(methylcarbamoyl)phenyl]-4,6-dioxo-2,3,5,6-tetrahydro-1H-benzo[g]pyrrolo[2,1-e]pteridin-8(4H)-yl]pentyl dihydrogen diphosphate (non-preferred name) |
|
 | A1BBB | Name: | 5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate) | Formula: | C10 H15 N2 O10 P | SMILES: | O=P(O)(O)OCC1OC(N2C=C(CO)C(=O)NC2=O)C(O)C1O | InChi: | InChI=1S/C10H15N2O10P/c13-2-4-1-12(10(17)11-8(4)16)9-7(15)6(14)5(22-9)3-21-23(18,19)20/h1,5-7,9,13-15H,2-3H2,(H,11,16,17)(H2,18,19,20)/t5-,6-,7-,9-/m1/s1 | Synonyms: | 5-(hydroxymethyl)uridine 5'-monophosphate | Definition date: | 2024-09-29 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | 5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate) |
|
 | A1BBE | Name: | {(3R,4R)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-hydroxypyrrolidin-3-yl}methyl dihydrogen phosphate | Formula: | C12 H18 N5 O5 P | SMILES: | O=P(O)(O)OCC1CN(Cc2c[NH]c3c2ncnc3N)CC1O | InChi: | InChI=1S/C12H18N5O5P/c13-12-11-10(15-6-16-12)7(1-14-11)2-17-3-8(9(18)4-17)5-22-23(19,20)21/h1,6,8-9,14,18H,2-5H2,(H2,13,15,16)(H2,19,20,21)/t8-,9+/m1/s1 | Definition date: | 2024-09-29 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | {(3R,4R)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-hydroxypyrrolidin-3-yl}methyl dihydrogen phosphate |
|
 | A1BBF | Name: | [(3R,4R)-4-hydroxy-1-{[5-(hydroxymethyl)pyridin-3-yl]methyl}pyrrolidin-3-yl]methyl dihydrogen phosphate | Formula: | C12 H19 N2 O6 P | SMILES: | O=P(O)(O)OCC1CN(Cc2cncc(CO)c2)CC1O | InChi: | InChI=1S/C12H19N2O6P/c15-7-10-1-9(2-13-3-10)4-14-5-11(12(16)6-14)8-20-21(17,18)19/h1-3,11-12,15-16H,4-8H2,(H2,17,18,19)/t11-,12+/m1/s1 | Definition date: | 2024-09-29 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | [(3R,4R)-4-hydroxy-1-{[5-(hydroxymethyl)pyridin-3-yl]methyl}pyrrolidin-3-yl]methyl dihydrogen phosphate |
|
 | A1BC6 | Name: | {[(3E)-4-{10-[(2S,3S,4R)-5-{[(R)-{[(R)-{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-2,3,4-trihydroxypentyl]-7,8-dimethyl-2,4-dioxo-2,3,4,10-tetrahydrobenzo[g]pteridin-5(1H)-yl}but-3-en-2-ylidene]amino}acetic acid (non-preferred name) | Formula: | C33 H42 N10 O17 P2 | SMILES: | O=C(O)CN=C(C)/C=C/N1c2cc(C)c(C)cc2N(CC(O)C(O)C(O)COP(=O)(O)OP(=O)(O)OCC2OC(n3cnc4c(N)ncnc43)C(O)C2O)C=2NC(=O)NC(=O)C1=2 | InChi: | InChI=1S/C33H42N10O17P2/c1-14-6-17-18(7-15(14)2)42(30-24(31(51)40-33(52)39-30)41(17)5-4-16(3)35-8-22(46)47)9-19(44)25(48)20(45)10-57-61(53,54)60-62(55,56)58-11-21-26(49)27(50)32(59-21)43-13-38-23-28(34)36-12-37-29(23)43/h4-7,12-13,19-21,25-27,32,44-45,48-50H,8-11H2,1-3H3,(H,46,47)(H,53,54)(H,55,56)(H2,34,36,37)(H2,39,40,51,52)/b5-4+,35-16?/t19-,20+,21+,25-,26+,27+,32+/m0/s1 | Definition date: | 2024-10-14 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | {[(3E)-4-{10-[(2S,3S,4R)-5-{[(R)-{[(R)-{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-2,3,4-trihydroxypentyl]-7,8-dimethyl-2,4-dioxo-2,3,4,10-tetrahydrobenzo[g]pteridin-5(1H)-yl}but-3-en-2-ylidene]amino}acetic acid (non-preferred name) |
|
 | A1BD6 | Name: | (3R,4R,5S)-3,4-dihydroxy-5-[(1R,2R,3S,4S,5R,6R,10E,14Z,16E,18Z)-1,2,3,4,5-pentahydroxy-6,20,20-trimethylhenicosa-10,14,16,18-tetraen-1-yl]oxolan-2-one | Formula: | C28 H46 O9 | SMILES: | OC1C(=O)OC(C(O)C(O)C(O)C(O)C(O)C(C)CCCC=CCC/C=CC=CC=C/C(C)(C)C)C1O | InChi: | InChI=1S/C28H46O9/c1-18(16-14-12-10-8-6-5-7-9-11-13-15-17-28(2,3)4)19(29)20(30)21(31)22(32)23(33)26-24(34)25(35)27(36)37-26/h7-11,13,15,17-26,29-35H,5-6,12,14,16H2,1-4H3/b9-7-,10-8+,13-11+,17-15-/t18-,19-,20+,21+,22-,23-,24-,25-,26+/m1/s1 | Definition date: | 2024-10-23 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | (3R,4R,5S)-3,4-dihydroxy-5-[(1R,2R,3S,4S,5R,6R,10E,14Z,16E,18Z)-1,2,3,4,5-pentahydroxy-6,20,20-trimethylhenicosa-10,14,16,18-tetraen-1-yl]oxolan-2-one (non-preferred name) |
|
 | A1BHU | Name: | (3S,3aS,4S,7R,8aS)-3-methylhexahydro-1H,3H-3a,7-epoxycyclohepta[c]furan-4-yl {(2S,3R)-3-hydroxy-4-[(4-methoxybenzene-1-sulfonyl)(2-methylpropyl)amino]-1-phenylbutan-2-yl}carbamate | Formula: | C32 H44 N2 O8 S | SMILES: | COc1ccc(cc1)S(=O)(=O)N(CC(C)C)CC(O)C(Cc1ccccc1)NC(=O)OC1CCC2CC3COC(C)C13O2 | InChi: | InChI=1S/C32H44N2O8S/c1-21(2)18-34(43(37,38)27-13-10-25(39-4)11-14-27)19-29(35)28(16-23-8-6-5-7-9-23)33-31(36)41-30-15-12-26-17-24-20-40-22(3)32(24,30)42-26/h5-11,13-14,21-22,24,26,28-30,35H,12,15-20H2,1-4H3,(H,33,36)/t22-,24-,26+,28-,29+,30-,32+/m0/s1 | Definition date: | 2024-11-20 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | (3S,3aS,4S,7R,8aS)-3-methylhexahydro-1H,3H-3a,7-epoxycyclohepta[c]furan-4-yl {(2S,3R)-3-hydroxy-4-[(4-methoxybenzene-1-sulfonyl)(2-methylpropyl)amino]-1-phenylbutan-2-yl}carbamate |
|
 | A1BHV | Name: | (3S,3aS,4R,7R,8aS)-3-methylhexahydro-1H,3H-3a,7-epoxycyclohepta[c]furan-4-yl {(2S,3R)-3-hydroxy-4-[(4-methoxybenzene-1-sulfonyl)(2-methylpropyl)amino]-1-phenylbutan-2-yl}carbamate | Formula: | C32 H44 N2 O8 S | SMILES: | COc1ccc(cc1)S(=O)(=O)N(CC(C)C)CC(O)C(Cc1ccccc1)NC(=O)OC1CCC2CC3COC(C)C13O2 | InChi: | InChI=1S/C32H44N2O8S/c1-21(2)18-34(43(37,38)27-13-10-25(39-4)11-14-27)19-29(35)28(16-23-8-6-5-7-9-23)33-31(36)41-30-15-12-26-17-24-20-40-22(3)32(24,30)42-26/h5-11,13-14,21-22,24,26,28-30,35H,12,15-20H2,1-4H3,(H,33,36)/t22-,24-,26+,28-,29+,30+,32+/m0/s1 | Definition date: | 2024-11-20 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | (3S,3aS,4R,7R,8aS)-3-methylhexahydro-1H,3H-3a,7-epoxycyclohepta[c]furan-4-yl {(2S,3R)-3-hydroxy-4-[(4-methoxybenzene-1-sulfonyl)(2-methylpropyl)amino]-1-phenylbutan-2-yl}carbamate |
|
 | A1BLX | Name: | (4S,7R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl)-7-(4-fluorophenyl)-4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione | Formula: | C23 H21 F N2 O6 | SMILES: | O=N(=O)c1cc(cc(OCC)c1O)C1CC(=O)NC=2CC(CC(=O)C1=2)c1ccc(F)cc1 | InChi: | InChI=1S/C23H21FN2O6/c1-2-32-20-10-14(8-18(23(20)29)26(30)31)16-11-21(28)25-17-7-13(9-19(27)22(16)17)12-3-5-15(24)6-4-12/h3-6,8,10,13,16,29H,2,7,9,11H2,1H3,(H,25,28)/t13-,16+/m1/s1 | Definition date: | 2024-12-17 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | (4S,7R)-4-(3-ethoxy-4-hydroxy-5-nitrophenyl)-7-(4-fluorophenyl)-4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione |
|
 | A1ASY | Name: | N-(1H-indol-5-yl)-4-[4-(propan-2-yl)piperazin-1-yl]-5,6,7,8-tetrahydroquinazolin-2-amine | Formula: | C23 H30 N6 | SMILES: | CC(C)N1CCN(CC1)c1nc(Nc2cc3cc[NH]c3cc2)nc2CCCCc12 | InChi: | InChI=1S/C23H30N6/c1-16(2)28-11-13-29(14-12-28)22-19-5-3-4-6-21(19)26-23(27-22)25-18-7-8-20-17(15-18)9-10-24-20/h7-10,15-16,24H,3-6,11-14H2,1-2H3,(H,25,26,27) | Definition date: | 2024-05-21 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | N-(1H-indol-5-yl)-4-[4-(propan-2-yl)piperazin-1-yl]-5,6,7,8-tetrahydroquinazolin-2-amine |
|
 | A1H2V | Name: | [(2~{R})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadecanoyloxy-propyl] octadecanoate | Formula: | C40 H79 O10 P | SMILES: | CCCCCCCCCCCCCCCCCC(=O)OC[CH](CO[P](O)(=O)OC[CH](O)CO)OC(=O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C40H79O10P/c1-3-5-7-9-11-13-15-17-18-20-21-23-25-27-29-31-39(43)47-35-38(36-49-51(45,46)48-34-37(42)33-41)50-40(44)32-30-28-26-24-22-19-16-14-12-10-8-6-4-2/h37-38,41-42H,3-36H2,1-2H3,(H,45,46)/t37-,38-/m1/s1 | Synonyms: | (2R,3S,4R,5R,6R)-6-((1R,2R,3S,4R,6S)-4,6-DIAMINO-2,3-DIHYDROXYCYCLOHEXYLOXY)-5-AMINO-2-(AMINOMETHYL)-TETRAHYDRO-2H-PYRA
N-3,4-DIOL | Definition date: | 2024-01-22 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | [(2~{R})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadecanoyloxy-propyl] octadecanoate |
|
 | A1H3P | Name: | (2~{S})-3-[(4-ethyl-1-benzofuran-7-yl)oxy]-2-fluoranyl-propan-1-ol | Formula: | C13 H15 F O3 | SMILES: | CCc1ccc(OC[CH](F)CO)c2occc12 | InChi: | InChI=1S/C13H15FO3/c1-2-9-3-4-12(17-8-10(14)7-15)13-11(9)5-6-16-13/h3-6,10,15H,2,7-8H2,1H3/t10-/m0/s1 | Definition date: | 2024-02-05 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | (2~{S})-3-[(4-ethyl-1-benzofuran-7-yl)oxy]-2-fluoranyl-propan-1-ol |
|
 | A1H3Q | Name: | (2~{R})-3-[(4-ethyl-1-benzofuran-7-yl)oxy]-2-fluoranyl-propan-1-ol | Formula: | C13 H15 F O3 | SMILES: | CCc1ccc(OC[CH](F)CO)c2occc12 | InChi: | InChI=1S/C13H15FO3/c1-2-9-3-4-12(17-8-10(14)7-15)13-11(9)5-6-16-13/h3-6,10,15H,2,7-8H2,1H3/t10-/m1/s1 | Definition date: | 2024-02-05 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | (2~{R})-3-[(4-ethyl-1-benzofuran-7-yl)oxy]-2-fluoranyl-propan-1-ol |
|
 | A1IUK | Name: | 1-[2-[5-[1-[bis(fluoranyl)methyl]-5-methyl-pyrazol-4-yl]-2,4-bis(fluoranyl)phenyl]-3-pyrimidin-4-yl-4,6-dihydropyrrolo[3,4-d]imidazol-5-yl]propan-1-one | Formula: | C23 H19 F4 N7 O | SMILES: | CCC(=O)N1Cc2nc(n(c3ccncn3)c2C1)c4cc(c(F)cc4F)c5cnn(C(F)F)c5C | InChi: | InChI=1S/C23H19F4N7O/c1-3-21(35)32-9-18-19(10-32)33(20-4-5-28-11-29-20)22(31-18)14-6-13(16(24)7-17(14)25)15-8-30-34(12(15)2)23(26)27/h4-8,11,23H,3,9-10H2,1-2H3 | Definition date: | 2024-11-20 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | 1-[2-[5-[1-[bis(fluoranyl)methyl]-5-methyl-pyrazol-4-yl]-2,4-bis(fluoranyl)phenyl]-3-pyrimidin-4-yl-4,6-dihydropyrrolo[3,4-d]imidazol-5-yl]propan-1-one |
|
 | A1IWR | Name: | (5-methyl-1,2-oxazol-3-yl)methanamine | Formula: | C5 H8 N2 O | SMILES: | Cc1onc(CN)c1 | InChi: | InChI=1S/C5H8N2O/c1-4-2-5(3-6)7-8-4/h2H,3,6H2,1H3 | Definition date: | 2024-12-19 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | (5-methyl-1,2-oxazol-3-yl)methanamine |
|
 | A1IWU | Name: | 5-(aminomethyl)pyridin-2-amine | Formula: | C6 H9 N3 | SMILES: | NCc1ccc(N)nc1 | InChi: | InChI=1S/C6H9N3/c7-3-5-1-2-6(8)9-4-5/h1-2,4H,3,7H2,(H2,8,9) | Definition date: | 2024-12-19 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | 5-(aminomethyl)pyridin-2-amine |
|
 | A1IWV | Name: | (3~{R})-piperidin-3-ol | Formula: | C5 H11 N O | SMILES: | O[CH]1CCCNC1 | InChi: | InChI=1S/C5H11NO/c7-5-2-1-3-6-4-5/h5-7H,1-4H2/t5-/m1/s1 | Definition date: | 2024-12-19 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | (3~{R})-piperidin-3-ol |
|
 | A1IWW | Name: | 2-methyl-~{N}'-oxidanyl-propanimidamide | Formula: | C4 H10 N2 O | SMILES: | CC(C)C(N)=NO | InChi: | InChI=1S/C4H10N2O/c1-3(2)4(5)6-7/h3,7H,1-2H3,(H2,5,6) | Definition date: | 2024-12-19 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | 2-methyl-~{N}'-oxidanyl-propanimidamide |
|
 | A1LXF | Name: | 2-[[(9R)-2-fluoranyl-7,7-bis(oxidanyl)-8-oxa-7-boranuidabicyclo[4.3.0]nona-1,3,5-trien-9-yl]methyl]prop-2-enoic acid | Formula: | C11 H11 B F O5 | SMILES: | OC(=O)C(=C)C[CH]1O[B-](O)(O)c2cccc(F)c12 | InChi: | InChI=1S/C11H11BFO5/c1-6(11(14)15)5-9-10-7(12(16,17)18-9)3-2-4-8(10)13/h2-4,9,16-17H,1,5H2,(H,14,15)/q-1/t9-/m1/s1 | Definition date: | 2024-02-01 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | 2-[[(9~{R})-2-fluoranyl-7,7-bis(oxidanyl)-8-oxa-7-boranuidabicyclo[4.3.0]nona-1,3,5-trien-9-yl]methyl]prop-2-enoic acid |
|
 | A1LYE | Name: | (3~{S},6~{S})-3-(1~{H}-imidazol-4-ylmethyl)-6-propan-2-yl-piperazine-2,5-dione | Formula: | C11 H16 N4 O2 | SMILES: | CC(C)[CH]1NC(=O)[CH](Cc2c[nH]cn2)NC1=O | InChi: | InChI=1S/C11H16N4O2/c1-6(2)9-11(17)14-8(10(16)15-9)3-7-4-12-5-13-7/h4-6,8-9H,3H2,1-2H3,(H,12,13)(H,14,17)(H,15,16)/t8-,9-/m0/s1 | Definition date: | 2024-02-16 | Last modified: | 2025-01-31 | Release date: | 2025-02-05 | Identifier: | (3~{S},6~{S})-3-(1~{H}-imidazol-4-ylmethyl)-6-propan-2-yl-piperazine-2,5-dione |
|